Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1231 of 5804
-
Peptide PET scan could light up hidden cancer targets
Diagnosis ENROLLING_BY_INVITATIONTumors are one of the major diseases threatening human health, among which solid tumors account for a considerable proportion. Nectin-4, as an important cell adhesion molecule, shows a highly expressed state in various solid tumors. In triple-negative breast cancer, the high expr…
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Placenta patch may help heal diabetic foot wounds
Disease control Recruiting nowThe purpose of this study is to determine how well our dHPT (Dehydrated Human Placental Tissue) Product and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic foot.
Phase: PHASE4 • Sponsor: Cellution Biologics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Measles mystery: how a virus both harms and helps immunity
Knowledge-focused Recruiting nowThe measles (MeV) paradox refers to an apparent contradiction: natural measles causes a transient but profound immune suppression putting patients at risk for opportunistic infections for years, while at the same time MeV infection induces robust immune activation leading to life…
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New hope for kidney cancer: ivonescimab trial launches
Disease control Recruiting nowTo learn if ivonescimab can help to control previously treated, locally advanced or metastatic ccRCC.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New cancer drug YL217 enters first human tests
Disease control Recruiting nowA Phase 1 First-in-Human study of YL217 in Patients with Advanced Solid Tumors
Phase: PHASE1 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New study aims to ease 'Brain Fog' after concussion
Symptom relief Recruiting nowPersistent memory symptoms after concussion are common, and likely perpetuated by unhelpful illness beliefs and coping behaviors. Results from a pilot study suggested that traditional cognitive rehabilitation and a novel cognitive-behavioral therapy (CBT) protocol were both assoc…
Phase: NA • Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Shock therapy vs. ketamine: which works better for severe depression?
Symptom relief CompletedThis study aimed to compare the efficacy, safety, and tolerability of electroconvulsive therapy (ECT) versus intravenous (IV) ketamine in adults with treatment-resistant major depressive disorder (TRD).
Phase: NA • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Brain test could match PTSD veterans to the right medication
Knowledge-focused Recruiting nowA substantial majority of Veterans with posttraumatic stress disorder (PTSD) continue to suffer even with the best current medications. Progress in developing more effective medications is hampered by the substantial variability within Veterans with PTSD, meaning the most effecti…
Phase: PHASE4 • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a nighttime sound machine help fight Alzheimer's?
Symptom relief ENROLLING_BY_INVITATIONThis proof-of-concept study explores whether long-term home-based closed-loop auditory stimulation during sleep enhances slow-wave activity (SWA) and yields preliminary efficacy signals in patients with amnestic mild cognitive impairment due to Alzheimer's disease (MCI-AD), confi…
Phase: NA • Sponsor: Bitbrain • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
AI takes on blood clotting: can ChatGPT guide surgeons on bleeding?
Knowledge-focused TerminatedThe goal of this observational validation study is to evaluate whether artificial intelligence (AI) models can accurately interpret ROTEM (Rotational Thromboelastometry) data and provide appropriate treatment recommendations in adult patients undergoing elective cardiac or liver …
Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can exercise and music beat dementia? a new study targets At-Risk veterans
Disease control Recruiting nowThis study will begin to evaluate personalized preventative dementia treatments for Veterans at risk for developing dementia. The investigators will target Veterans with Motoric Cognitive Risk syndrome (MCR), which is characterized by slow gait speed and cognitive concerns (e.g.,…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New heart ablation technique could tame dangerous rhythms in adults born with heart defects
Disease control TerminatedThis is a prospective, single-arm intervention trial whereby we will test the safety and efficacy of performing pulmonary vein isolation (PVI) using pulsed field ablation (PFA) in adult patients with congenital heart disease (CHD) who are presenting for atrial tachycardia (AT) ab…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a smartphone app help prevent sudden infant death?
Prevention Recruiting nowSudden Unexplained Infant Death (SUID) is the leading cause of death in infants age 28 days to 1 year. Protective factors, such as supine positioning, firm sleep surface, breastfeeding, pacifier use, elimination of soft objects from the sleep space, and avoidance of tobacco, alco…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jul 17, 2026 00:00 UTC
-
New insulin algorithm aims to tame type 2 diabetes
Disease control CompletedThe purpose of the study is to assess the safety and efficacy of a next generation automated insulin delivery algorithm in adults with type 2 diabetes aged 16-70 years old
Phase: NA • Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Magnetic pulses to the brain may calm anxiety in Parkinson's — a trial puts it to the test
Symptom relief ENROLLING_BY_INVITATIONParkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's dementia. Anxiety in PD is common, has major effects on quality of life and contributes to increased disability. The reported prevalence of anxiety in PD ranges widely and is estimated …
Phase: NA • Sponsor: HealthPartners Institute • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New registry study tests antibody drugs for rare nerve disease
Disease control Recruiting nowThe primary objective of this registry study is to evaluate the therapeutic efficacy and safety profiles of distinct monoclonal antibody-based therapies for aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorders within the Chinese population under real-…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:35 UTC
-
Promising combo targets tough esophageal cancer in small trial
Disease control Recruiting nowIn the era of immunotherapy, the standard second-line treatment regimen for locally advanced/metastatic esophageal squamous cell carcinoma (ESCC) remains controversial. This prospective, single-center, single-arm phase II clinical study aims to evaluate the efficacy and safety of…
Phase: PHASE2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a simple pill help save sight in wet AMD?
Disease control Recruiting nowThis study will evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of Oral HX9428 tablets in patients with wet age-related macular degeneration(wAMD)
Phase: PHASE1, PHASE2 • Sponsor: Fujian Haixi Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
AI tool aims to predict Post-Surgery complications in breast cancer patients
Knowledge-focused Recruiting nowSurvival after breast cancer has increased due to early diagnosis and advances in treatment methods. Musculoskeletal problems related to cancer and its treatment constitute a significant part of the daily practice of physiatrists and rehabilitation specialists involved in oncolog…
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Brain zaps for young minds: can TMS ease anxiety and depression?
Symptom relief Recruiting nowIn this open-label trial, the overall aim is to determine if TMS treatment can improve anxiety and depression in a broad group of children and youth referred by physicians.
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC